Monoclonal Antibodies Over Time: What’s Changed?
Monoclonal antibodies (or mAbs) are special proteins made by identical immune cells that all come from the same original cell. These proteins are designed to recognize and attach to specific targets, like viruses, bacteria, or cancer cells. Since 2014, the FDA has approved at least five new monoclonal antibody treatments every year, and that number […]
